Borderline low testosterone sits near the clinical cutoff for deficiency but doesn't always mean treatment is needed. The AUA and the Endocrine Society each set guideline-based thresholds for total testosterone, and both require confirmation on two fasting early-morning draws plus symptoms before a diagnosis is considered (Mulhall et al., 2018; Bhasin et al., 2018). When a result sits near the lower limit of the reference range, providers weigh free testosterone, SHBG, reversible causes, and symptom severity before making a treatment decision. At-home hormone testing through a testosterone panel gives men a starting point, but a borderline result marks the beginning of a workup, not a diagnosis.
Approximately 30% of men whose first draw comes back low will normalize on a second test (Bhasin et al., 2018). That rate is the reason both the Endocrine Society and the AUA require confirmatory testing before any diagnosis is made.
What Does Borderline Low Testosterone Mean?
A borderline result falls near the lower limit of the laboratory reference range for total testosterone. The AUA and the Endocrine Society each define a guideline-based threshold, and the two don't align exactly (Mulhall et al., 2018; Bhasin et al., 2018). Lab-specific ranges differ further depending on the assay method, and healthy testosterone ranges shift with age, body composition, and assay standardization. The Endocrine Society recommends CDC Hormone Standardization Program-certified assays to reduce misclassification.
A man whose total testosterone falls just below the cutoff at one lab may test above it at another. That variation is part of why a single number, drawn once, can't confirm or exclude a deficiency.
Why a Single Low Result Doesn't Confirm a Diagnosis
Testosterone fluctuates by time of day, fasting status, illness, and stress. Morning levels peak between 7 and 10 a.m. and can drop substantially by the afternoon, which is why guidelines specify early-morning draws (Bhasin et al., 2018).
The standard diagnostic protocol calls for two separate early-morning fasting draws, typically 1-3 weeks apart, using the same lab and assay (Mulhall et al., 2018; Bhasin et al., 2018). Both must come back below the reference threshold. No current guideline supports starting testosterone replacement therapy on a single blood draw.
The repeat requirement matters. An acute illness, a short night of sleep, or recent high-intensity training can temporarily suppress production. Confirming that the level is persistently low separates a true deficiency from a transient dip.
Free Testosterone, SHBG, and What One Number Can Miss
Total testosterone measures both bound and unbound hormone. Most circulating testosterone is protein-bound, primarily to sex hormone-binding globulin (SHBG) and albumin. Only a small unbound fraction reaches tissues.
When total testosterone is borderline, free testosterone measured by equilibrium dialysis or a validated calculation often changes the clinical picture (Bhasin et al., 2018). Obesity and type 2 diabetes tend to lower SHBG, which can keep total testosterone in the borderline range while free testosterone remains adequate. Aging, liver disease, and hyperthyroidism do the opposite, raising SHBG so that a man with a total testosterone in the normal range may still have a free level that is clinically low.
Checking free testosterone alongside SHBG can help reduce misclassification in either direction. A total testosterone testalone can mislead when binding protein levels fall outside the typical range.
Common Reasons Testosterone Sits Near the Cutoff
Borderline levels often have an identifiable and sometimes reversible cause. Excess body fat is one of the most common. Adipose tissue is associated with increased aromatase activity, which may convert more testosterone to estradiol and contribute to lower circulating levels. NHANES data identified obesity as a strong independent predictor of low testosterone. Meaningful weight loss may improve total testosterone levels in men with obesity, sometimes enough to shift the result out of the borderline range.
Obstructive sleep apnea is associated with lower testosterone levels, and treatment of the sleep disorder may improve hormone levels in some men. Medications are another frequent contributor: opioids, certain antidepressants, and glucocorticoids all suppress the hypothalamic-pituitary-gonadal axis, and changing or tapering the medication sometimes restores production.
When LH and FSH come back low or inappropriately normal alongside low testosterone, the cause may be pituitary or hypothalamic rather than testicular. Prolonged sedentary behavior was also an independent predictor in the NHANES dataset, separate from body weight.
Does Borderline Low Testosterone Always Require Treatment?
No. Both the Endocrine Society and the AUA recommend addressing reversible causes first (Bhasin et al., 2018; Mulhall et al., 2018). Weight loss, improved sleep, treatment of sleep apnea, and medication review may improve testosterone levels and symptoms in men whose levels are borderline.
Testosterone replacement therapy is considered only when levels remain persistently low on two morning draws, symptoms are present, reversible causes have been addressed, and the clinician and client agree the benefits justify the risks. The Endocrine Society frames this as a shared decision-making process with discussion of expected benefits and known harms, not a threshold-triggered prescription.
A pre-TRT panel captures the baseline labs needed for that conversation: total and free testosterone, SHBG, estradiol, hematocrit, PSA, and pituitary markers. Men considering treatment should also discuss fertility with their provider, since exogenous testosterone commonly suppresses sperm production to a variable degree and recovery isn't guaranteed (Mulhall et al., 2018).
What Risks Come with Treating Borderline Levels?
Treating a borderline result carries similar risks to treating a confirmed deficiency, because the same medication is used. The TRAVERSE trial, one of the largest randomized controlled trials of testosterone therapy (5,246 men, mean follow-up 33 months), found that the primary cardiovascular endpoint did not differ between groups: major adverse cardiac events occurred at similar rates in the testosterone and placebo arms (Lincoff et al., 2023).
That neutral primary finding doesn't account for the secondary signals. The testosterone group had higher rates of atrial fibrillation (3.5% vs. 2.4%), pulmonary embolism (0.9% vs. 0.5%), and acute kidney injury (2.3% vs. 1.5%).
The FDA updated class-wide labeling for all testosterone products in February 2025, removing certain cardiovascular boxed-warning language based on TRAVERSE data while adding a blood pressure warning (FDA, 2025). Hematocrit monitoring is standard during therapy: multiple guidelines flag elevated hematocrit as a threshold prompting clinical intervention, such as a dose adjustment or therapeutic phlebotomy (Bhasin et al., 2018; Mulhall et al., 2018).
How Providers Evaluate a Borderline Result
The diagnostic path follows a standard sequence. No step is optional.
|
Step |
What it involves |
|
First morning draw (fasting, 7-10 a.m.) |
Total testosterone, ideally by LC/MS assay |
|
Repeat draw (1-3 weeks later, same conditions) |
Confirms whether the low level persists |
|
Expanded panel |
Free testosterone, SHBG, LH, FSH, estradiol, hematocrit, PSA |
|
Clinical evaluation |
Symptom assessment, medication review, screening for sleep apnea and metabolic conditions |
|
Reversible-cause review |
Address weight, sleep, medications, and alcohol before considering TRT |
A provider who initiates TRT on a single draw without symptom evaluation and without screening for reversible causes isn't following current guidelines. The process determines whether a borderline number reflects a true deficiency or a correctable underlying condition.
Men who prepare for a blood draw by fasting, testing in the morning, and avoiding recent illness get the most accurate baseline. Tracking results through a bundled lab panel over time helps separate a persistent low from a one-time dip.
Borderline low testosterone doesn't demand immediate treatment. It demands proper evaluation, the right labs, and an honest conversation about whether the result explains the symptoms. For men whose levels stay persistently low and whose symptoms don't resolve with lifestyle changes, TRT is a reasonable option, prescribed after clinical evaluation and monitored for safety over time. For men whose levels normalize on a second draw, the borderline label disappears with it.
Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.
FAQs
What total testosterone level is considered borderline low?
The AUA and the Endocrine Society each define a guideline-based threshold for low total testosterone, and the two don't align exactly (Mulhall et al., 2018; Bhasin et al., 2018). A result near the lower limit of the reference range falls in a gray zone where the number alone doesn't confirm or exclude a deficiency. Free testosterone and SHBG testing often clarify whether the level reflects a true clinical problem.
Can borderline low testosterone return to normal without treatment?
Yes, in many cases. Approximately 30% of initially low results normalize on repeat testing (Bhasin et al., 2018). Weight loss, treatment of sleep apnea, and medication adjustments can also raise testosterone enough to move out of the borderline range without hormone therapy.
Does a single low testosterone reading mean TRT is needed?
No. Both the Endocrine Society and the AUA require two separate fasting early-morning blood draws before diagnosis (Mulhall et al., 2018). A single result can reflect a temporary dip caused by illness, poor sleep, or time of day.
How does free testosterone change the picture when total testosterone is borderline?
SHBG levels determine how much testosterone is bound versus free. Obesity lowers SHBG, which can make total testosterone appear borderline while free testosterone stays adequate. Aging and liver disease raise SHBG, potentially leaving a man with a normal-appearing total testosterone but a clinically low free level (Bhasin et al., 2018).
What did the TRAVERSE trial find about testosterone therapy safety?
The TRAVERSE trial (5,246 men, mean follow-up 33 months) showed a neutral primary cardiovascular endpoint, with major adverse cardiac events occurring at similar rates in the testosterone and placebo groups (Lincoff et al., 2023). Secondary signals included higher rates of atrial fibrillation, pulmonary embolism, and acute kidney injury in the testosterone group.
Does starting testosterone therapy permanently stop sperm production?
Exogenous testosterone commonly suppresses sperm production, but the degree of suppression and the timeline for recovery vary between individuals. Recovery isn't guaranteed, and guidelines require providers to discuss fertility goals before starting therapy (Mulhall et al., 2018).
Why do different labs report different normal ranges for testosterone?
Assay methods and reference populations vary between laboratories. The Endocrine Society recommends CDC Hormone Standardization Program-certified assays to reduce variability (Bhasin et al., 2018). A man whose total testosterone falls just below the cutoff at one lab may test above it at another using a different method.
References
Share:
Can Regular Doctors Do A Hormone Test? What To Know
Blood Test Before Starting HRT: Which Labs You Need